Nomiyama T, Kawanami T, Irie S, Hamaguchi Y, Terawaki Y, Murase K, et al
Of those women, 40 were also using hormone therapy and 80 werent.Glucagon-like peptide-1 (GLP-1) drugs mimic the GLP-1 hormone, which helps control insulin and blood sugar levels, decreases appetite and slows digestion of food.The information garnered through this new study provides important insights to develop more effective and personalized weight management interventions to reduce a postmenopausal womans risk of overweight and obesity-related health complications, senior researcher Dr
These medications provide substantial metabolic benefits, yet fertility restoration and pregnancy timing must guide treatment decisions
Current limitations in MC4-focused appetite investigations primarily involve receptor specificity, neural-circuit resolution, and long-term intracellular signaling characterization across varied experimental systems